Natixis Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Natixis lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 36.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 30,428 shares of the biotechnology company’s stock after selling 17,375 shares during the quarter. Natixis’ holdings in Axon Enterprise were worth $18,084,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Asset Dedication LLC grew its stake in Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after buying an additional 18 shares during the period. Bleakley Financial Group LLC boosted its position in Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC increased its holdings in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after purchasing an additional 21 shares in the last quarter. Burns Matteson Capital Management LLC raised its position in Axon Enterprise by 3.4% in the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock valued at $450,000 after purchasing an additional 25 shares during the period. Finally, Transcend Capital Advisors LLC raised its position in Axon Enterprise by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company’s stock valued at $431,000 after purchasing an additional 25 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Stock Performance

AXON opened at $559.53 on Friday. The stock’s 50 day simple moving average is $556.27 and its 200-day simple moving average is $566.46. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $42.87 billion, a PE ratio of 144.58, a P/E/G ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Analyst Ratings Changes

A number of brokerages have commented on AXON. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Needham & Company LLC reissued a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. One analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $626.45.

Read Our Latest Report on AXON

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.